OSL — Oncosil Medical Share News
0.000.00%
Last trade - 00:00- AU$22.24m
- AU$15.78m
- AU$1.82m
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval
Refile: BUZZ-Australia's OncoSil Medical rises on cancer device FDA review progress
Brief: Oncosil Medical Seeks Trading Halt
Brief: Oncosil Medical Receives TGA Approval In Australia
Australia's OncoSil Medical soars on regulatory nod for cancer device
Australia's Oncosil Medical at two-week high on robust quarterly results
Brief: Oncosil Medical Says Q3 Revenue Increased 49% VS PCP
Australia's OncoSil Medical drops to record low on discounted capital raise
Brief: Oncosil Medical Announces A$8.0 Million Capital Raise At A$0.68/ Share
Brief: Oncosil Medical Seeks Trading Halt
Brief: Oncosil Medical Seeks Trading Halt
Brief: Oncosil Medical Appoints Thomas Duthy As Non-Executive Chairman
Brief: Oncosil Medical Reports FY Loss Attributable A$15.1 Million
Australia's Oncosil Medical hits record low on discounted capital raise
Brief: Oncosil Medical Says A$8.7M Capital Raise At Issue Price A$0.003 Per Share
Brief: Oncosil Medical Seeks Trading Halt